NFL rookie Nic Scourton is suffering from a collapsed lung. The second-round pick initially began showing symptoms during a ...

The U.S. Food and Drug Administration has approved Insmed's daily bronchiectasis pill, brensocatib, which will be sold under ...

The U.S. Food and Drug Administration has approved Insmed's oral drug for a type of lung disease, the company said on Tuesday ...

The U.S. Food and Drug Administration (FDA) has approved Insmed’s daily pill brensocatib, which will be sold under the brand ...

A first-in-class reversible dipeptidyl peptidase-1 (DPP-1) inhibitor, brensocatib addresses the underlying inflammatory ...

Will Lewis, Insmed CEO, joins 'Fast Money' to discuss the company's lung drug being greenlit by the FDA and what it means for ...

In 2021, ATYR completed a phase 1b/2a trial in pulmonary sarcoidosis, and have since started a phase 3 trial. Currently the ...

Secondhand Smoke: Even non-smokers can be affected by the smoke inhaled from others, particularly in enclosed spaces. Studies show that individuals regularly exposed to secondhand smoke have a higher ...

For Hairston, the lack of urgency expressed not only by MSHA but also elected officials who he feels should prioritize miners ...

Tristan Rogers’ passing from lung cancer despite being a non-smoker raises awareness about hidden risks, causes, and ...

The A5 nanobody is around 10 times smaller than conventional antibodies, helping it to penetrate deep into tissues. Crucially, it can bind selectively to cancer cells, leading to a reduction of more ...

In a significant research advancement that may help inform treatment strategies for millions of patients worldwide, a ...